Medication info
VYROUJEONG 10/10 mg

VYROUJEONG 10/10 mg

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›10mg / 1 tablet
Manufacturer / importer
Samchundang Pharmaceutical Co., Ltd.
Appearance
White to pale yellow double convex rectangular tablet
Packaging
30 tablets ((10 tablets/Alu-Alu) x 3)
Approval status
Active

MFDS item code 201601724 · Approved 2016.03.31

Summary

Main use
Treatment of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range for this medicine is 10/10mg~10/40mg daily. The generally recommended initial dose is 10/20mg daily. Patients who require less reduction in LDL cholesterol may start with 10/10mg daily. After starting treatment with this medicine or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of 4 weeks or more. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken this medicine at 10/80 mg for 12 months or more without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg daily, administered once daily in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see section on patients with abnormal liver function under 5. General Precautions in Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this medicine at 10/20mg once daily in the evening. If higher doses of this medicine are administered to these patients, use caution and monitor them closely (see 5. General Precautions under Precautions for Use). Administration to elderly patients No dose adjustment is necessary in elderly patients. Concomitant administration with other medicines (See 6. Interactions under Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed a dose of 10/20mg/day of this medicine.

Ingredients

Manufacturer
Samchundang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia

  • Hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular diseases
  • dyslipidemia
View approved original text

This medication helps lower elevated total cholesterol, LDL cholesterol, ApoB proteins, and triglycerides in patients with primary hypercholesterolemia, particularly heterozygous familial and non-familial hypercholesterolemia, and mixed hyperlipidemia, while also increasing HDL cholesterol. It can additionally be used as an adjunct in patients with homozygous familial hypercholesterolemia or as monotherapy when other treatments are ineffective. This medication is administered alongside an appropriate diet and is recommended when diet alone is insufficient. Treatment of lipid-related diseases should be conducted after confirming any impact from other medical conditions or medications, with regular blood lipid testing for management. This medication plays a crucial role in lowering the risk of atherosclerotic vascular diseases due to hypercholesterolemia, contributing to the improvement of patient health.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range for this medicine is 10/10mg~10/40mg daily. The generally recommended initial dose is 10/20mg daily. Patients who require less reduction in LDL cholesterol may start with 10/10mg daily. After starting treatment with this medicine or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of 4 weeks or more. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken this medicine at 10/80 mg for 12 months or more without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg daily, administered once daily in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see section on patients with abnormal liver function under 5. General Precautions in Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this medicine at 10/20mg once daily in the evening. If higher doses of this medicine are administered to these patients, use caution and monitor them closely (see 5. General Precautions under Precautions for Use). Administration to elderly patients No dose adjustment is necessary in elderly patients. Concomitant administration with other medicines (See 6. Interactions under Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed a dose of 10/20mg/day of this medicine.

Precautions

This medication may cause muscle-related side effects such as myopathy and rhabdomyolysis; therefore, if symptoms like muscle pain or weakness occur, consult a doctor immediately. This medication should not be used by those with hypersensitivity to its components, active liver disease patients, or during pregnancy and lactation. Especially during pregnancy, it can interfere with cholesterol biosynthesis essential for normal fetal development, so it should be discontinued immediately upon confirmation of pregnancy. This medication should not be taken in conjunction with certain potent CYP3A4 inhibitors, gemfibrozil, cyclosporine, or danazol as they increase the risk of myopathy. Additionally, patients who are genetically unable to digest lactose should avoid this medication. Patients with severe myasthenia gravis or ocular myasthenia should use this medication cautiously, and treatment should be discontinued if symptoms worsen. Liver function abnormalities may occur during treatment with this medication; therefore, patients with a history of liver disease or symptoms should undergo regular liver function tests. Due to numerous drug interactions, if taking other medications, be sure to inform your physician or pharmacist and exercise caution. This medication is also available for elderly patients; however, some elderly may be more sensitive to side effects, so caution is warranted. Women of childbearing potential should use appropriate contraceptive methods during treatment to avoid pregnancy and consult their physician if planning pregnancy. Nursing mothers should discontinue breastfeeding when taking this medication, and safety in children and adolescents has not been sufficiently confirmed, so it should be used cautiously. In the event of overdose, specific antidotes are unavailable; general treatment will be provided based on symptoms. Any unexplained muscle pain, weakness, tenderness, etc., during the course of this medication should be reported to a physician immediately, and regular check-ups and monitoring are necessary.

Side effects

Myopathy, rhabdomyolysis, elevated creatine kinase, headache, diarrhea, influenza, upper respiratory tract infection, myalgia, limb pain, fatigue, abdominal pain, viral infection, pharyngitis, sinusitis, arthralgia, low back pain, cough, anaphylaxis, urticaria, rash, angioedema, elevated liver aminotransferase levels, hepatitis, thrombocytopenia, nausea, pancreatitis, dizziness, paresthesia, depression, cholelithiasis, cholecystitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, eosinophilia, drug reaction with systemic symptoms, erythema multiforme, liver damage, myasthenia, cataracts, constipation, dyspepsia, flatulence, nausea, eczema, pruritus, rash, muscle cramps, specific cranial nerve dysfunction, taste disturbance, ophthalmoplegia, facial paresis, tremor, peripheral neuropathy, peripheral nerve palsy, mental disorder, anxiety, sleep disorder, insomnia, nightmares, cognitive impairment, myasthenic syndrome, oculobulbar weakness, interstitial lung disease, thrombocytopenia, leukopenia, hemolytic anemia, positive antinuclear antibody, increased erythrocyte sedimentation rate, arthritis, photosensitivity, fever, chills, flushing, malaise, dyspnea, cholestatic jaundice, liver steatosis, cirrhosis, fulminant liver necrosis, liver cancer, liver failure, alopecia, various skin changes, lichenoid drug eruption, gynecomastia, decreased libido, erectile dysfunction, oculomotor paralysis, anemia, elevated aminotransferases, elevated ALP, elevated gamma-GT, increased bilirubin levels, thyroid dysfunction, elevated serum creatine kinase, transient liver function test abnormalities, increased HbA1c, elevated fasting blood glucose levels, edema, thirst, facial swelling, syncope, insomnia, gastritis, atrophic gastritis, mucus stools, irritable bowel syndrome, sore throat, nocturia, hematuria, increased serum creatine phosphokinase, weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from exposure to air or moisture. It is also important to maintain room temperature between 1°C to 30°C when storing the medication. This helps to safely preserve the effectiveness of the medication for a longer time.

Appearance and packaging

Appearance

White to pale yellow double convex rectangular tablet

Package unit

30 tablets ((10 tablets/Alu-Alu) x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.